Posts by: Maureen Newman

Maureen Newman

Maureen Newman is a senior Science and Research writer for Cystic Fibrosis News Today. Maureen is currently a PhD student studying biomedical engineering at University of Rochester, working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit's laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment.

August 19, 2015August 19, 2015

Thalidomide Helps Refractory UC Patients Achieve and Maintain Remission

News, Ulcerative colitis

Results from an 8-week clinical trial coupled with an 8-week trial extension show evidence that children with refractory ulcerative colitis (UC) can achieve and maintain remission when treated with the ... Read more

April 9, 2015April 9, 2015

Stem Cells Heal Crohn’s Fistula in Clinical Trial

Crohn's Disease, News

Patients with Crohn’s fistula may benefit from therapy with autologous adipose-derived stem cells (ASCs), according to the results of a phase 2 clinical trial conducted by five medical institutions in collaboration ... Read more

March 26, 2015September 28, 2016

Mongersen Shows Promise for Crohn’s Disease

Colon Cancer, Crohn's Disease, News

A new treatment for Crohn’s disease is showing promise in clinical trials. Giuliani, an Italian pharmaceutical company, conducted a phase 2 clinical study of more than 150 adult patients with Crohn’s disease ... Read more

November 3, 2014September 28, 2016

IBD, Myasthenia Gravis a Prevalent Co-Existing Autoimmune Condition Pair

IBD News, News

Inflammatory bowel disease (IBD) affects a wide variety of patients, especially those with concurrent autoimmune diseases. According to a presentation given by Francisco de Assis Aquino of the Universidade Federal ... Read more

October 7, 2014October 7, 2014

Whole-Foods Diet May Protect Against Leaky Gut and Multiple Sclerosis Progression

Crohn's Disease, IBD News, News, Ulcerative colitis

A decade ago, Shahram Lavasani, PhD, from Lund University in Sweden, was hard-pressed to find fellow scientists who agreed “leaky gut syndrome” could play a role in multiple sclerosis. “Back ... Read more

October 3, 2014October 3, 2014

Further Data Support Safety, Efficacy of Takeda’s Entyvio for UC, Crohn’s

Crohn's Disease, News, Ulcerative colitis

Takeda Pharmaceuticals, which is on the forefront of treating ulcerative colitis and Crohn’s disease with the newly launched Entyvio (vedolizumab), will present data concerning the open-label extension phase 3 study ... Read more

September 22, 2014September 28, 2016

Salix’s UCERIS Granted Tentative FDA Approval for Distal Ulcerative Colitis

News, Ulcerative colitis

Salix Pharmaceuticals may soon bring a new treatment for mild-to-moderate distal ulcerative colitis to the market with its tentative Food and Drug Administration (FDA) approval for UCERIS (budesonide) rectal foam. ... Read more

August 29, 2014September 28, 2016

ULTRA 1, 2, 3 Demonstrate Safety and Efficacy of Adalimumab in Ulcerative Colitis

News, Ulcerative colitis

Three clinical trials — one an open-label extension study, evaluating adalimumab (Humira) in patients with moderately to severely active ulcerative colitis — were recently reviewed in an article from collaborators at ... Read more

August 25, 2014August 25, 2014

Low Dose Naltrexone May Alleviate Crohn’s Disease Symptoms

Crohn's Disease, News

For patients with incurable diseases such as Crohn’s disease, new treatments to help maintain symptom remission can provide hope for living a more comfortable life. One proposed treatment under investigation ... Read more

August 21, 2014August 21, 2014

Vitamin D Found to Reduce Colon Cancer Risk in Mice with IBD

Colon Cancer, IBD News, News

Vitamin D, a powerhouse vitamin that is associated with numerous health benefits, is now associated with lowering the risk for colon cancer. The laboratory of Dr. Lillian Maggio-Price in the Department ... Read more